Jeffrey A. Meckler - 08 Aug 2024 Form 4 Insider Report for Indaptus Therapeutics, Inc. (INDP)

Role
CEO and Director, Director
Signature
/s/ Jeffrey Meckler
Issuer symbol
INDP
Transactions as of
08 Aug 2024
Net transactions value
+$310,002
Form type
4
Filing time
08 Aug 2024, 17:30:46 UTC
Previous filing
10 May 2024
Next filing
30 Sep 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INDP Common stock Award $155,001 +84,932 +113% $1.82 160,306 08 Aug 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INDP Common Stock Warrants Award $155,001 +84,932 $1.82 84,932 08 Aug 2024 Common Stock 84,932 $1.70 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person acquired 84,932 shares of common stock and 84,932 warrants to purchase common stock from the Issuer for an aggregate purchase price of $155,000.90.